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Glycopeptides with TN antigen (GaINAc)Ser/Thr and T-antigen structures (I3Gall-3GalNAc)Ser/Thr, de-
scribed as tumor-associated antigens, were synthesized and coupled to bovine serum albumin. Alterna-
tively, synthetic methods for the construction of 13-anomeric analogues of the TN and T-antigen glyco-
peptides were developed, aiming at antigenic structures having a varied stereochemistry of the linkage
between the carbohydrate and the peptide moiety. As a furthertype ofpotential tumor-associated antigen,
fucosyl-chitobiose asparagine glycopeptides were synthesized, deprotected, and coupled to bovine serum
albumin. The chemical methods developed now make the complex sensitive glycoprotein partial structures
accessible in analytically pure form and in preparative amounts.
Introduction
Carbohydrate structures of the outer cell membrane
glycoproteins are suspected to exhibit decisive functions
in intercellular communication and in the regulation of
cell growth (1). In agreement with this molecular
mechanistic aspect, it has been found that abnormal cell
growth and tumor development parallel a dramatic
change in the structures of membrane glycoproteins (2).
The altered glycoproteins of the tumor cell membranes
seem to be tumor-associated antigens. In this sense,
Springer and colleagues reported in a number of articles
that glycoproteins of the TN and T-antigen type rep-
resent tumor-associated antigen structures (3) (Fig. 1).
According to their results, these structures occur in
exposed formn only in epithelial tumors, whereas they
are not present in normal cells of the same tissues (4).
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FIGURE 1. Glycoproteins of the TN (1) and T-antigen (2).
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Synthetic Glycopeptides with TN and
T-Antigen Structure
With the aim ofmakingrelatedglycopeptides avail-
able for immunological evaluations, we have elabo-
rated selective syntheses ofcompounds with such tu-
mor-associated antigen structures (5). The coupling
of the synthetic glycopeptide antigens to bovine
serum albumin was achieved by applying a special
carbodiimide procedure in water without introducing
an artificial linker component to give the conjugates
3 and 4 (Fig. 2). According to the carbohydrate analy-
sis data, the conjugate 3 contains an average of 25
synthetic glycopeptide units coupled to the protein,
whereasconjugate4carries38T-antigenglycopeptide
units per protein molecule. The synthetic antigens 3
and 4 have the particular advantage thatthey are not
microheterogeneousinthecarbohydratepart. Themi-
croheterogeneity of glycoproteins isolated from bio-
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FIGURE 2. Structures of the synthetic antigens 3 and 4.KUNZ ET AL.
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FIGURE 3. Reaction of glycosyl fluoride (5) with allyloxycarbonyl
serine benzyl ester (6) to produce a glycoconjugate with galacto-
samine 3-glycosidically linked to serine or threonine (7).
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FIGURE 5. Synthesis ofabranched fucosylated chitobiosyl amine.
FIGURE 4. An N-glycoprotein fucosylated in the core region.
logical sources often causes serious difficulties in im-
munological applications and leads to irreproducible
effects.
Recent results of investigations on tumor-associ-
ated immunodeterminant glyean structures suggest
that the T-antigen disaccharide analogue with ,B-ano-
meric configuration at the penultimate galactosamine
unit, rather than the natural T-antigen 2 itself, shows
a tumor-associated reactivity (6). Therefore, we
changedtheconceptoftheglycopeptide synthesesand
now aimed at structures containing galactosamine 3-
glycosidically linked to serine or threonine. The syn-
thesis of glycoconjugates with these structural fea-
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tures was achieved, for example, by reacting the gly-
cosyl fluoride with allyloxyearbonyl serine benzyl es-
ter (Fig. 3).
In spite of the non-neighboring group active pro-
tection of the glycosyl donor 5, the 13-anomeric con-
jugate is obtained selectively. The method is of fun-
damental importance for the projected syntheses of
3-anomerically linked TN and T-antigenglycopeptide
analogues. An alternative route for the synthesis of
P-analogous TN and T-antigen glycopeptides consists
in Koenigs-Knorr type reactions ofthe corresponding
glycosyl bromides with serine and threonine deriva-
tives with modified protecting group compositions.
The efficiency ofthis concept could be demonstrated
in principle by a p-selective conjugation of the T-
antigen disaccharide with threonine.
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FIGURE 6. Synthesis of a saccharide asparagine conjugate.
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Fucosyl Chitobiose-Asparagine
Glycopeptides
N-Glycoproteins fucosylated in the core region have
also been suspected to be structures associated with
tumor membranes (7). Therefore, glycopeptides oftype
8 (Fig. 4)were selected as anothergoalin oursyntheses
of antigenic structures.
The synthesis ofthe branched fucosylated chitobiosyl
amine requires some 20 steps. During the further pro-
cessingofthetrisaccharide asparagine conjugate9(Fig.
5), the allyloxycarbonyl (Aloc) protecting group was re-
vealed to be a very efficient and selective tool (8). It is
removable quite selectively and almost quantitatively
by means of a palladium-catalyzed allyl transfer to the
weakly basic morpholine. Subsequent chain extension
yielded the trisaccharide tripeptide 10 (Fig. 5), a struc-
ture which is part ofan influenza virus neuraminidase.
Theprojectedremovalofthe C-terminaltert-butylester
protection, a precondition for the immunological eval-
uation of the synthetic glycopeptide, was shown to be
impossible.
The treatment of compounds like 10 (Fig. 5) with
trifluoroacetic acid resulted in complete cleavage ofthe
fucoside bond. To overcome this serious problem in the
synthesis of fucosylated glycopeptides, a new trisac-
charide synthesis was elaborated. It aimed at the syn-
thesis of a saccharide asparagine conjugate 11 (Fig. 6)
that exclusively carries acetyl protecting groups in the
carbohydrate moiety.
The synthesis of conjugate 11 requires almost 30
steps. The useful Aloc protecting method allowed a
highly efficient and selective deblocking and N-terminal
chain extension. The selective cleavage of the C-ter-
minal tert-butyl ester ofthe resulting trisaccharide tri-
peptide using trifluoroacetic acid was now achieved
without destruction of the fucoside bond. The selec-
tively deblocked product could be condensed efficiently
with a tripeptide ester to form the corresponding tri-
saccharide hexapeptide, aprotected partial sequence of
an envelope glycoprotein of a murine leukemia virus.
Further C-terminal deprotection and removal ofthe
ester groups from the carbohydrate part delivered the
free fucosyl chitobiose glycopeptide 12, which is inter-
estingasavirusenvelopestructureaswellasapotential
tumor-associated antigen. Glycopeptide 12 was then
coupled to bovine serum albumin by applying the
method elaborated for the T-antigen glycopeptide. The
conjugate obtained contains about 12% carbohydrate.
It is currently being investigated forimmunological ap-
plications.
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